Ciaran Murray is the Chief Executive Officer of ICON. He joined ICON as Chief Financial Officer in 2005, serving in that capacity until his appointment as Chief Executive.  Prior to joining ICON, he held a number of senior financial positions in global organisations including Kraft Foods. Novell Inc. Northern Foods and Codec Systems.

He graduated with a Bachelor of Commerce degree from the University College Dublin and qualified as a Chartered Accountant with PwC
 

Eimear has served as the Vice President Strategic Human Resource since April 2007, having previously held the position of Vice President Human Resources for ICON Clinical Research Europe and Rest of World since joining the company in November 1999.

Prior to joining ICON Ms. Kenny was HR Manager for GE Global Consumer Finance Ireland. Ms. Kenny holds a degree in both business studies Portobello college, Dublin & human resource management from the national college of Ireland. She is also a member of the Chartered Institute of Personnel and Development .

Simon Holmes has served as Vice President Group Marketing and Market Development since November 2007.

In this role Mr Holmes is responsible for ICON's global marketing function and for managing ICON's internal process for the proactive identification and evaluation of potential acquisition candidates. Prior to this role, Mr.Holmes was Group Director of Marketing, a position he assumed on joining ICON in July 2005. Mr. Holmes has held senior positions within Microsoft, LogicaCMG and Cable and Wireless.

A graduate of the University of East Anglia and Cambridge University he holds an MBA from the UCD Smurfit Business School

Michael McGrath is Snr Vice president of Group Information Technology for ICON PLC. He joined ICON in December 2002 having previously held a number of senior IT positions in the Financial Service Industry with GE Capital and Woodchester Bank Ltd. Prior to this he worked as an IT Consultant and also as a Software Engineer.

He has over 15 years experience in IT Industry across many areas including Pharmaceuticals, Financial Services and Utilities. He holds an MSc in Information Technology Management and a Degree in Electronic

Diarmaid Cunningham is ICON's General Counsel.  Diarmaid joined ICON as General Counsel in November 2009 having spent 10 years with A&L Goodbody which is one of Ireland's premier corporate law firms.  Diarmaid was appointed Company Secretary in October 2011.
 
Diarmaid graduated with a Bachelor of Business and Legal Studies from University College Dublin in 1997 and qualified as a Solicitor with A&L Goodbody in 2001.

Dr. Mark A. Quigley is the Sr. Vice President of Corporate Quality and Compliance.  He has over 30 years of experience in the pharmaceutical industry and comes to ICON from Sanofi Aventis where he was VP of Quality and Compliance.

Mark has held management positions in several areas of pharmaceutical research & developments including, clinical research, pharmacovigilance, regulatory affairs and quality assurance.  He has also held an academic appointment as an adjunct professor at the University of Missouri – School of Pharmacy.

He received a B.S. in Pharmacy,  M.S. and PhD in pharmaceutical science from the University of Missouri, is a licensed pharmacist, and holds certification as a fraud examiner.
 

Dr. Steve Cutler was appointed Group President, Clinical Research Services in November 2011.

Steve has over 23 years’ experience within the pharmaceutical and CRO industry and joined ICON from Kendle where he held the position of Chief Executive Officer, having previously served as Kendle’s Chief Operating Officer. Prior to Kendle, Steve spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Steve held positions with Sandoz (now Novartis) in Australia and Europe. He holds a B.Sc. and a PhD from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).

Dr. Mario Rocci joined ICON as the former CEO of Prevalere Life Sciences, Inc. (a wholly owned subsidiary of ICON plc) in 2008. He served as Executive Vice President of Global Bioanalytical Sciences, overseeing ICON’s expanding Bioanalytical Sciences group, until his current appointment as President, ICON Development Solutions.

Mario's 29 years of industry experience includes positions such as Head of the Laboratory of Investigative Medicine and Research Associate Professor of Medicine at Thomas Jefferson University, where he was part of a team of Clinical Pharmacologists conducting Phase I-IV clinical studies on drugs undergoing development. Dr. Rocci was also a Clinical Associate Professor of Pharmacy Practice at the Philadelphia College of Pharmacy and Science.

Actively involved in the industry, Dr. Rocci served as the 2004 President of the American Association of Pharmaceutical Scientists (AAPS), a professional society of over 12,000 members, having previously been elected to a three year term on the AAPS Board of Directors. He also serves on the Board of Directors for the International Pharmaceutical Federation (FIP) and is Chairman of the Board of the Product Quality Research Institute (PQRI). He has authored over 125 scientific publications and has extensive experience in the pharmaceutical sciences and the regulatory requirements of the FDA.

Dr. Rocci earned a Ph.D. in Pharmaceutics and a B.S. in Pharmacy from the State University of New York at Buffalo.
 

Ted Gastineau is the CEO and co-founder of ICON Medical Imaging (Beacon Bioscience).a leading specialist CRO in the medical imaging field. In 2004, ICON acquired a 70% interest in Beacon and acquired the remaining 30% stake in January 2009.

Prior to Beacon, Ted co-founded Intelligent Imaging, a research company specializing in imaging, which was acquired by Quintiles in 1997. From 1997-2000 he served as Senior Vice-President and Business Unit Head within Quintiles. Ted has more than 15 years in imaging for drug development and has worked closely with industry, FDA, and academia to establish best practices in place today.

Ted has held academic positions with the University of Maryland, John Hopkins School of Medicine, Cambridge University and the Smithsonian Institution. He holds a bachelors degree in Zoology and pursued PhD in neurophysiology prior to founding Intelligent Imaging.